​
​

Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

OverviewForecastRevenueFinancialsChart

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 80.00% institutional investors, 0.95% insiders, and 19.05% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.47% of RPTX shares. ARK Genomic Revolution is the top mutual fund, with 5.87% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRepare Therapeutics80.00%0.95%19.05%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution2.49M5.87%-107.78K
ARK Genomic Revolution ETF2.49M5.86%11.97K
Nikko Gbl All Biological Genome Eq MF297.64K0.70%-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH75.00K0.18%-
Vanguard Health Care ETF54.97K0.13%-128.00
Range Cancer Therapeutics ETF50.44K0.12%-
Biotech Growth Ord49.26K0.12%-
Vifag 2002 SICAV35.00K0.08%-
Avantis US Small Cap Equity ETF28.48K0.07%-
SPDR® S&P® International Small Cap ETF20.01K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 01, 2024Segal Lloyd Mitchell PRESIDENT AND CEOSell$11.53K
Mar 28, 2024Segal Lloyd Mitchell PRESIDENT AND CEOSell$12.24K
Mar 28, 2024Forte Steve EVP, CHIEF FINANCIAL OFFICERSell$3.81K
Apr 01, 2024Forte Steve EVP, CHIEF FINANCIAL OFFICERSell$3.64K
Mar 28, 2024Zinda Michael EVP, CHIEF SCIENTIFIC OFFICERSell$2.09K

Insider Transactions Trends

DateBuySell
2024 Q2-4
2024 Q1-16
2023 Q49-
2023 Q2-3
2023 Q1--

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 80.00%, followed by 0.95% insiders and 19.05% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 45.35%, which Repare Therapeutics exceeds.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.47%), Blue owl capital lp (3.37M shares, 7.99%), and Orbimed advisors (3.32M shares, 7.87%). Together, they hold 40.32% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 11.30% of its assets in 2.65M Repare Therapeutics shares, valued at 8.73M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution is the top mutual fund holder of Repare Therapeutics shares, with 5.87% of its total shares outstanding invested in 2.49M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools